Results 241 to 250 of about 51,658 (311)

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial. [PDF]

Infect Dis Ther
Martinon-Torres F, Virta MM, Koski S, de la Cueva IS, Szymanski HT, Bosis S, Drăgănescu AC, Silfverdal SA, Zambrano B, Dhingra MS, B'Chir S, Syrkina O, Lyabis O, Vasquez GA, Rehm C, MET58 Study Group.   +15 more
europepmc   +1 more source

Safety and coverage of Pneumosil pneumococcal polysaccharide conjugate vaccine (10-valent PCV) in a camp for internally displaced persons in Somaliland

Catherine R. McGowan, Kevin van Zandvoort, Saed Ibrahim, Abdirahman Ibrahim Hassan, Abdikarim Mohamed Ahmed, Mohamed Ali Magan, Mohamed Hussein Muhumed, Marwa F. Mohamed, Rachael Cummings, Saied Ali, Marwa F. Mohamed, Mohamed Ahmed Saed, Mustapha Ahmed Karim, Mohamed Abdi Hergeye, Stefan Flasche, Francesco Checchi   +15 more
openalex   +1 more source

Correction to: Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]

Open Forum Infect Dis
europepmc   +1 more source

The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children. [PDF]

PLOS Glob Public Health
Haeusler IL, Kagucia EW, Bottomley C, Otiende M, Nyiro J, Scott JAG.   +5 more
europepmc   +1 more source

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population. [PDF]

Infect Dis Ther
Fiévez S, Ta A, Bellier L, Blanc E, El Khoury JY, Beillat M, Sabra A, Sivignon M, Ilic A, Perdrizet J.   +9 more
europepmc   +1 more source

Immunogenicity, safety and adverse events of sequential vaccination with a 10-valent pneumococcal conjugate vaccine (PCV10) and PPSV23 compared with PPSV23 alone in systemic lupus erythematosus. [PDF]

Lupus Sci Med
Chatterjee R, Kommaraju SY, Mettingal Ramakrishnan S, Ravikumar KL, Aggarwal A.   +4 more
europepmc   +1 more source

Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina Faso. [PDF]

Vaccine
Childs L, Zoma RL, Ouedraogo I, Sawadogo G, Tarbangdo TF, Zoma A, Ouangraoua S, Dama E, Tran T, Akhter F, Utreja S, Ouattara M, Verani JR, Sanou S, Aké HF, McGee L, Kobayashi M.   +16 more
europepmc   +1 more source

SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants. [PDF]

Vaccine
Carroll M, Fox HB, Tran A, Chellappan G, Rojas LV, Karengil G, Karandish F, Langston JW, Fall BM, Whalen MM, McCluskie MJ, Durocher Y, Datta A, Kapre SV, Olave IA.   +14 more
europepmc   +1 more source